Filter
267
Text search:
Licensed
pharmaceutical
products
Featured
14
64
Language
Document type
105
74
43
26
14
3
2
Countries / Regions
23
10
9
7
7
7
7
7
6
6
5
5
5
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
137
15
11
10
7
5
1
Toolboxes
48
48
19
8
6
4
4
4
4
3
3
2
2
1
1
1
1
1
1
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Access to controlled medicines. 3rd edition
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been
...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
Med J DY Patil Univ 2017;10:229-33
First Revised Edition
March 2000
this Service Delivery brief provides evidence-based strategies that can help support drug shops and pharmacies in providing a wider variety of family planning methods and information. Evidence shows that with training and support, pharmacy and drug shop staff can facilitate the use of a broad range
...
Kenya Quality Model for Health - Level 2 Facilities
